Terpenes in the management of chronic kidney disease

被引:1
|
作者
Kulkarni, Piyusha [1 ]
Yeram, Pranali B. [1 ]
Vora, Amisha [1 ]
机构
[1] Shri Vile Parle Kelavani Mandals Narsee Monjee Ins, Shobhaben Pratapbhai Patel Sch Pharm & Technol Man, Mumbai 400056, India
关键词
Chronic kidney disease (CKD); Terpenes; Renal dysfunction; Acute Kidney Disease (AKI); GLYCATION END-PRODUCTS; DIABETES-MELLITUS; OXIDATIVE STRESS; ANTIINFLAMMATORY ACTIVITY; HYPERTENSION; INJURY; INFLAMMATION; COMPLICATIONS; HYPERGLYCEMIA; EPIDEMIOLOGY;
D O I
10.1007/s00210-024-03098-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic kidney disease (CKD) is a chronic and progressive systemic condition that characterizes irreversible alterations in the kidneys' function and structure over an extended period, spanning months to years. CKD is the one of the major causes of mortality worldwide. However, very limited treatment options are available in the market for management of the CKD. Diabetes and hypertension are the key risk factors for the progression of CKD. It is majorly characterised by glomerulosclerosis, tubular atrophy, and interstitial fibrosis. Plants are considered safe and effective in treating various chronic conditions. A diverse group of phytoconstituents, including polyphenols, flavonoids, alkaloids, tannins, saponins, and terpenes, have found significant benefits in managing chronic ailments. Terpenes constitute a diverse group of plant compounds with various therapeutic benefits. Evidence-based pharmacological studies underscore the crucial role played by terpenes in preventing and managing CKD. These substances demonstrate the capacity to hinder detrimental pathways, such as oxidative stress, inflammation and fibrosis, thereby demonstrating benefit in renal dysfunction. This review offers a comprehensive overview of the roles and positive attributes of commonly occurring terpenes in managing the causes and risk factors of CKD and the associated conditions.
引用
收藏
页码:6351 / 6368
页数:18
相关论文
共 50 条
  • [1] Disease management in chronic kidney disease
    Rastogi, Anjay
    Linden, Ariel
    Nissenson, Allen R.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2008, 15 (01) : 19 - 28
  • [2] Management of anemia in chronic kidney disease
    Gomez, J. M. Lopez
    NEFROLOGIA, 2008, 28 : 63 - 66
  • [3] Guidelines for the management of chronic kidney disease
    Levin, Adeera
    Hemmelgarn, Brenda
    Culleton, Bruce
    Tobe, Sheldon
    McFarlane, Philip
    Ruzicka, Marcel
    Burns, Kevin
    Manns, Braden
    White, Colin
    Madore, Francoise
    Moist, Louise
    Klarenbach, Scott
    Barrett, Brendan
    Foley, Robert
    Jindal, Kailash
    Senior, Peter
    Pannu, Neesh
    Shurraw, Sabin
    Akbari, Ayub
    Cohn, Adam
    Reslerova, Martina
    Deved, Vinay
    Mendelssohn, David
    Nesrallah, Gihad
    Kappel, Joanne
    Tonelli, Marcello
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (11) : 1154 - 1162
  • [4] Handbook of Chronic Kidney Disease Management
    Pugh-Clarke, Karen
    JOURNAL OF RENAL CARE, 2011, 37 (02) : 123 - 123
  • [5] Management of hypertension in chronic kidney disease
    Townsend, Raymond R.
    Taler, Sandra J.
    NATURE REVIEWS NEPHROLOGY, 2015, 11 (09) : 555 - 563
  • [6] Anemia management in chronic kidney disease
    Fishbane, Steven
    Nissenson, Allen R.
    KIDNEY INTERNATIONAL, 2010, 78 : S3 - S9
  • [7] Management of hypertension in chronic kidney disease
    Pasquale Zamboli
    Luca De Nicola
    Roberto Minutolo
    Valerio Bertino
    Fausta Catapano
    Giuseppe Conte
    Current Hypertension Reports, 2006, 8
  • [8] Management of Hypertension in Chronic Kidney Disease
    Pugh, Dan
    Gallacher, Peter J.
    Dhaun, Neeraj
    DRUGS, 2019, 79 (04) : 365 - 379
  • [9] Management of patients with chronic kidney disease
    Francesco P. Schena
    Internal and Emergency Medicine, 2011, 6
  • [10] Management of hypertension in chronic kidney disease
    Raymond R. Townsend
    Sandra J. Taler
    Nature Reviews Nephrology, 2015, 11 : 555 - 563